期刊文献+

葡萄球菌对大环内酯类抗生素耐药性检测 被引量:2

Detection of resistance in Staphylococci to marcolide antibiotics
下载PDF
导出
摘要 目的检测临床分离的葡萄球菌(金黄色葡萄球菌和表皮葡萄球菌)对大环内酯类抗生素的耐药性。方法用琼脂稀释法测定328株葡萄球菌(金葡菌185株,表皮葡萄球菌143株)对红霉素、罗红霉素、阿奇霉素、克林霉素的最低抑菌浓度(MIC)值,用D实验检测红霉素对克林霉素的诱导耐药性。结果耐甲氧西林金葡菌对红霉素、罗红霉素、阿奇霉素和克林霉素的耐药率分别为90·7%、96·9%、97·9%和84·5%;甲氧西林敏感金葡菌对红霉素、罗红霉素、阿奇霉素和克林霉素的耐药率分别为79·5%、75%、76·1%和72.7%。耐甲氧西林表皮葡萄球菌对红霉素、罗红霉素、阿奇霉素的耐药率均为100·0%,对克林霉素的耐药率为99·1%;甲氧西林敏感表皮葡萄球菌对红霉素的耐药率为94·1%,对罗红霉素、阿奇霉素、克林霉素的耐药率均为97·1%。19株对红霉素耐药、克林霉素敏感的金黄色葡萄球菌,D试验阳性9株(9/19);2株对红霉素耐药、克林霉素敏感的表皮葡萄球菌,D试验均阴性。结论葡萄球菌对大环内酯类抗菌药物耐药显著,此类药物不宜用于葡萄球菌感染的治疗。 Objective To survey the bacterial resistance to macrolides in staphylococci isolated from Anhui hospitals. Methods MICs of 4 kinds of macrolides against 328 clinical isolates of Staphylococci were determined by agar dilution method. The inducible resistance of erythromycin to clindamcin was checked by D-test. Results The resistance rates of MRSA to erythromycin, roxithromycin, azithromycin, clindamycin were 90.7%, 96.9%, 97. 9%, 84. 5%, respectively. The resistance rates of MSSA to erythromycin, roxithromycin, azithromycin and clindamycin were 79. 5%, 75%, 76. 1% and 72. 7%. The resistance rates of MRSE strains to erythromycin, roxithromycin and azithromycin were 100%, and that to clindamycin was 99. 1%. The resistance rate of MSSE to erythromycin was 94. 1%, and that to roxithromycin, azithromycin were 97. 1%. Among 19 strains of staphylococcus aureus with erythromycin resistant and clindamycin sensitive, D-test positive strains were 9 (9/19), which phenotypes were iMLS. Among 2 strains of staphylococcus epidermidis with erythromycin resistant and clindamycin sensitive, D-test were negative, whose phenotypes were MS. Conclusion The resistant rates of staphylococci to macrolides are so high that macrolides should not be used for the treatment of infections caused by these isolates.
出处 《安徽医科大学学报》 CAS 北大核心 2007年第3期338-340,共3页 Acta Universitatis Medicinalis Anhui
基金 安徽省自然科学基金资助项目(编号:050430804)1
关键词 葡萄球菌 金黄色 大环内酯类 药物耐受性 staphylococcus aureus macrolides drug tolerance
  • 相关文献

参考文献12

  • 1Pittet D,Wenzel R P.Nosocomial bloodstream infections[J].Arch Intern Med,1995,155(7):1177-84.
  • 2Steinberg J P,Clark C C,Hackman B O.Nosocomial and community-acquired Staphylococcus aureus bacteriemias from 1980 to 1993.Impact of intravascular devices and methicillin resistance[J].Clin Infect Dis,1996,23(6):255-9.
  • 3马越,姚蕾,陈鸿波,李景云,张力,胡昌勤,金少鸿.中国51家医院2000年葡萄球菌属临床分离株的耐药性[J].中国抗感染化疗杂志,2002,2(1):24-26. 被引量:59
  • 4Edmond M B,Wallace S E,McClish D K,et al.Nosocomial bloods-tream infections in the United States hospitals:A three year analysis[J].Clin Infect Dis,1999,29(3):239-44.
  • 5Fiebelkorn K R,Crawford S A,McElmeel M L,et al.Practical diskdiffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci[J].J Clin Microbiol,2003,41(5):4740-4.
  • 6Clinical and Laboratory Standards Institute,Performance standards for antimicrobial susceptibility testing.Sixteenth informational supplement[S].2006:M100-S16.
  • 7Melo-Cristino J.Antimicrobial resistance in Staphylococci and Enterococci in 10 Protuguese hospital in 1996 and 1997.POSGAR.Protuguese Study Group of Antimicrobial Resistance[J].Microb Drug Resist,1998,4(1):19-24.
  • 8曹鸿霞,熊自忠,王中新,徐元宏,李旭.耐甲氧西林金黄色葡萄球菌检测及其耐药性研究[J].安徽医科大学学报,2006,41(5):579-581. 被引量:6
  • 9Siberry G K,Tekle T,Carroll K,et al.Failure of clindamycin treatment of methicillin-resistant Staphylococcus aureus expressing inducible clindamycin resistance in vitro[J].Clin Infect Dis,2003,37(6):1257-60.
  • 10Levin T P,Suh B,Axelrod P,et al.Potential clindamycin resistance in clindamycin-susceptible,erythromycin-resistant Staphylococcus aureus;report of clinical failure[J].Antimicrob Agents Chemother,2005,49(8):1222-4.

二级参考文献20

  • 1NCCLS.Performance standards for antimicrobial susceptibility testing[S].Fourteenth informational supplement M100-S14,2004,24:46.
  • 2Lina G,Quaglia A,Reverdy EM,et al.Distribution of genes encoding resistance to macrolides,lincosamides and streptogramins among staphylococci [J].Antimicrob Agent Chemother,1999,43 :1062-1066.
  • 3Roberts MC,Sutcliffe J,Courvalin P,et al.Nomenclature for,macrolide and macrolide-lincosamide-streptogamin B resistance determinants [J].Antimicrob Agents Chemother,1999,43:2823-2830.
  • 4Weisblum B,Demohn V.Erythromycin-inducible resistance in Staphylococcus aureus:survey of antibiotic classes involved [J].J Bacteriol,1969,98:447-452.
  • 5Iordanescu S.Three distinct plasmids originating in the same Staphylococcus aureus strain[J].Arch Roum Pathol Exp Microbiol,1976,35:111-118.
  • 6NCCLS.Performance standards for antimicrobial susceptibility testing [S].Fifteenth informational supplement M100-S15,2005,25:141.
  • 7Pittet D,Wenzel RP.Nosocomial bloodstream infections[J].Arch.Intern Med,1995,155:1177-1184
  • 8Steinberg JP,Clark CC,Hackman BO.Nosocomial and community-acquired Staphylococcus aureus bacteriemias from 1980 to 1993.Impact of intravascular devices and methicillin resistance[J].Clin Infect Dis,1996,23:255-259
  • 9Edmond MB,Wallace SE,McClish DK,et al.Nosocomial bloodstream infections in the united States hospitals: A three year analysis.[J].Clin Infect Dis,1999,29:239-244
  • 10Lautenschlager S,Herzog C,Zimmerli W,et al.Course and outcome of bacteriemia due to Staphylococcus aureus: evaluation of different clinical case definitions[J].Clin Infect Dis,1993,16:567-573

共引文献71

同被引文献33

引证文献2

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部